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METHODOLOGY Open Access
Analysis of cluster randomised stepped
wedge trials with repeated cross-sectional
samples
Karla Hemming1*, Monica Taljaard2,3 and Andrew Forbes4
Abstract
Background: The stepped wedge cluster randomised trial (SW-CRT) is increasingly being used to evaluate policy or
service delivery interventions. However, there is a dearth of trials literature addressing analytical approaches to the
SW-CRT. Perhaps as a result, a significant number of published trials have major methodological shortcomings,
including failure to adjust for secular trends at the analysis stage. Furthermore, the commonly used analytical
framework proposed by Hussey and Hughes makes several assumptions.
Methods: We highlight the assumptions implicit in the basic SW-CRT analytical model proposed by Hussey and
Hughes. We consider how simple modifications of the basic model, using both random and fixed effects, can be
used to accommodate deviations from the underlying assumptions. We consider the implications of these
modifications for the intracluster correlation coefficients. In a case study, the importance of adjusting for the secular
trend is illustrated.
Results: The basic SW-CRT model includes a fixed effect for time, implying a common underlying secular trend
across steps and clusters. It also includes a single term for treatment, implying a constant shift in this trend under
the treatment. When these assumptions are not realistic, simple modifications can be implemented to allow the
secular trend to vary across clusters and the treatment effect to vary across clusters or time. In our case study, the
naïve treatment effect estimate (adjusted for clustering but unadjusted for time) suggests a beneficial effect.
However, after adjusting for the underlying secular trend, we demonstrate a reversal of the treatment effect.
Conclusion: Due to the inherent confounding of the treatment effect with time, analysis of a SW-CRT should
always account for secular trends or risk-biased estimates of the treatment effect. Furthermore, the basic model
proposed by Hussey and Hughes makes a number of important assumptions. Consideration needs to be given to
the appropriate model choice at the analysis stage. We provide a Stata code to implement the proposed analyses
in the illustrative case study.
Keywords: Stepped wedge, Cluster randomised trial, Analysis, Secular trends
Background
Stepped wedge cluster randomised trials (SW-CRTs),
that is, trials in which clusters are randomised to be-
come exposed to an intervention sequentially over time
[1–3], are rapidly increasing in popularity. In the con-
ventional version of this design, which is the focus in
this paper, all clusters are initially observed in the
unexposed condition; then at usually regular intervals,
one or more clusters are sequentially randomised to be-
come exposed to the intervention and remain exposed
for the duration of the study. The study continues until
all clusters are exposed. Outcomes may be assessed on
cross-sectional samples of individuals from each cluster
at multiple discrete time points, on the same cohort
followed over time, or as mixture of the two. In this
paper we focus on the cross-sectional design. Examples
of interventions evaluated using the stepped wedge de-
sign include changes to the way that health services are
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delivered and health care professional training interven-
tions [4–7].
A characteristic feature of this design is that the evalu-
ation happens over an extended period of time in which
the proportion of clusters exposed to the intervention
gradually increases. This means that the control clusters
will, on average, contribute observations from an earlier
calendar time than the intervention clusters. In evalua-
tions of policy changes and service delivery interven-
tions, there may be secular changes in the outcome
caused by external forces such as changes in the way
that care is delivered. Thus, calendar time may be asso-
ciated with the outcome in addition to its association
with exposure to the intervention and so is a potential
confounder [3, 5]. Stepped wedge studies that do not ad-
just for time (i.e. do not allow for the possibility of secu-
lar trends) are, therefore, potentially biased [3]. Whilst a
recent, small, systematic review identified that 8 of a
total of 10 studies adjusted for secular trends [8], results
from our own larger review of 32 published trials identi-
fied that only 17 (53%) clearly allowed for the secular
trends within the primary estimate of the treatment ef-
fect (unpublished result) [9]; and another review has
shown that only 61 out of 102 trials mentioned time ef-
fects in the analysis [10]. In the early history of cluster
randomised trials it was not unusual to see trial results
published without allowing for clustering, thus yielding
results which were overly precise. This remained a
prevalent problem for years [11–13]. A similar situation
has already started to arise in the SW-CRT literature
wherein trialists are failing to adjust for time [14]. In
fact, failure to account for time has even appeared in the
recent methodological literature [15]. This is potentially
a greater problem than failing to adjust for clustering, as
it has implications for bias as well as for precision.
Another important consideration in stepped wedge tri-
als is that the basic analytical model proposed by Hussey
and Hughes [16] makes a number of assumptions. These
assumptions may be under-appreciated by some clinical
trialists, as sensitivity to their departure is rarely investi-
gated or considered at the analysis stage. Yet, these
model assumptions are different and more restrictive
than assumptions made in the related framework pro-
posed for the analysis of cluster cross-over trials [17].
Furthermore, whilst others have started to appreciate
these assumptions when determining the sample size
needed in a stepped wedge trial [18], there is no single
paper which addresses all of these issues with respect to
statistical analysis.
In this paper, our objectives are to (1) review the as-
sumptions implicit in the basic Hussey and Hughes
model and to consider their implications; (2) consider
how these models can be extended to allow for devia-
tions from assumptions, including heterogeneity in the
secular trend and in the treatment effect and (3) discuss
the importance of adjusting for secular trends. We present
a case study to demonstrate the application of the pro-
posed model extensions and to show how trial conclu-
sions can differ as a result of adjusting for secular trends.
Methods
The defining feature of the SW-CRT is that clusters are
randomised to initiate the intervention at different
points in time. We define the points at which clusters
are randomised to cross from the control to intervention
as ‘steps’. Figure 1 presents a schematic illustration of
the SW-CRT. The simplest stepped wedge study design
has one cluster crossing over at each step (i.e. has the
same number of steps as clusters) and has one additional
measurement point to the number of steps (i.e. a prein-
tervention measurement). Where more than one cluster
switches at each step we refer to this as a group of clus-
ters. Variations on the common design include multiple
measurement points before any randomisation occurs or
after all clusters have switched, steps between which no
measurements are taken, and steps between which mul-
tiple measurements are taken.
Case study: a SW-CRT to evaluate a training package to
promote sweeping of the membranes
The UK body, the National Institute of Health and Clin-
ical Excellence (NICE), recommends sweeping of the
membranes at term to reduce induction of labour, but it
is known that many women do not receive a membrane
sweep. A pragmatic SW-CRT of 10 midwifery teams
(with teams forming the clusters) was undertaken to
evaluate whether a training package to promote sweep-
ing of the membranes in post-term women is effective
[19]. These 10 midwifery teams were split across two dif-
ferent hospitals, with 5 teams serving each hospital and
hospital used as a stratification factor in the randomisa-
tion. The timing of the introduction of the intervention
in each cluster was randomly allocated and evaluated
using a slightly modified version of the stepped wedge
cluster design (Fig. 2). Time was categorised into 39
Group of 
clusters
Cross sectional design
Group 1
2 Control
3 Intervention
4
T1 T2 T3 T4 T5
Fig. 1 Schematic illustration of the stepped wedge cluster
randomised trial
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time periods (each representing a week) with each birth
occurring over the study duration being classified into
the appropriate cluster by time period. The study in-
cluded 2864 low-risk women over 39 weeks’ gestation
and ran from 5 March 2012 to 26 November 2012. The
primary outcome was whether or not the women had a
membrane sweep. The next section commences with
analysis methods for continuous outcomes then de-
scribes natural extensions for binary outcomes – applic-
able to our case study.
Basic model
Hussey and Hughes [16] have suggested a model-based
approach for analysing data from a cross-sectional SW-
CRT. This approach was proposed for continuous out-
come variables and has been commonly used at the de-
sign stage of these studies [9]. It involves fitting a linear
mixed model:
Y ijl ¼ β0 þ βj þ θXij þ ui þ eijl;
where i indexes the cluster, j indexes time and l in-
dexes the individual, with Yijl a continuous outcome.
The term ui ~N(0, σu
2) represents a cluster-level random
effect, eijl ~N(0, σ(e)
2 ) the individual error terms, X is a
binary variable representing exposure to the treatment
(1 for treatment, 0 otherwise), θ is the treatment effect.
Following Hussey and Hughes, βj represents a fixed cat-
egorical effect to model the underlying secular trend (βT
= 0 for identifiability where T is the total number of
measurement periods) and β0 an intercept term which
represents the population average during the first time
interval. It is convenient to think of ui representing the
time invariant deviation of the ith cluster from the popu-
lation average.
The intracluster correlation coefficient (ICC) which,
under this model, is assumed constant over time, is
then:
ρ ¼ σ
2
u
σ2u þ σ2e
:
Hussey and Hughes consider models for continuous
outcomes with an identity link (to report mean differ-
ence). But, this approach naturally extends to generalised
linear mixed models for other outcome types (e.g. binary
as in the case study), other link functions (e.g. logit) and
consequently, other scales for the treatment effect (e.g.
odds ratio (OR)).
It is important to recognise the underlying assump-
tions of the basic Hussey and Hughes model, both with
respect to fixed and random components. Most notably,
the model includes a fixed effect for time (implying a
common underlying secular trend across all clusters)
and a single term for treatment (implying a constant
shift in this trend under the treatment). In the basic
model the effect of time is modelled as a categorical
variable which allows for a piecewise secular trend. The
model additionally implies a simple correlation struc-
ture, whereby the correlation between any two observa-
tions in the same cluster is the same regardless of
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Fig. 2 Schematic representation of study design for case study
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treatments administered and duration between the time
periods of the observations.
The model also assumes that the data obtained, at
multiple discrete time points, are on different individ-
uals. However, whilst the data are assumed measured at
discrete points in time in this model, the actual mea-
surements might be obtained in continuous time (as in
our case study) but categorised into time intervals de-
fined by the steps.
We first consider extensions in which the assumption
about the secular trend is relaxed and then move on to
consider extensions in which the treatment effect is
allowed to vary in some way. These extensions are incor-
porated either by extending the fixed or random compo-
nents of the model. Each extension makes implicit
modifications to the assumptions about the correlation
structures – we outline these along the way. For clarity
we build the models up in a stepwise process. For nota-
tional clarity, fixed effects are represented using Greek
letters and random effects using lower case Roman let-
ters. We use θ throughout to denote the treatment ef-
fect, sometimes with a subscript to indicate a treatment
effect that varies across some factor.
Extensions to allow different secular trends
In the basic Hussey and Hughes model, a homogeneous
secular trend is assumed across all clusters. Whilst the
underlying secular trend may not be of substantive inter-
est, a misspecified secular trend may lead to biased treat-
ment effects or biased standard errors. Random
deviations (across clusters) from the underlying secular
trend have already been proposed in the context of clus-
ter cross-over designs and cluster trials with repeated
cross-sectional measurements [17, 20, 21]. Such devia-
tions have also been proposed in stepped wedge trials in
the context of design and efficiency considerations [22,
23]. We consider extensions to the basic model to allow
for variation in the secular trend across clusters, first
using fixed effects and then using random effects.
Model extension A: varying secular trends across strata of
clusters – using fixed effects
Secular trends might vary across clusters or defined sub-
groups of clusters (i.e. strata). For example, in our case
study involving stratified allocation of midwifery teams
within two separate hospitals, it may be reasonable to
allow for different secular trends in each hospital. This
can be accomplished by adding a fixed-effect interaction
between time and stratum to the basic model:
Y i sð Þjl ¼ β0 þ βj þ θXi sð Þj þ γ jsZi sð Þ þ ui þ ei sð Þjl;
where Yi(s)jl indicates that cluster i is nested within
stratum s, Zi(s) is an indicator for stratum and γjs
represents the fixed time by stratum interaction (con-
strained such that γjs is 0 for the last strata). One natural
choice might be to treat any stratification grouping used
in the randomisation procedure as strata. This model ex-
tension, modifying the fixed-effects components only,
makes no modifications to the underlying correlation
structure.
Model extension B: varying secular trends across clusters –
using random effects
Secular trends might also be allowed to vary randomly
across clusters, rather than across fixed subgroups of
clusters. This can be incorporated by extending the
random-effects components to allow a random inter-
action between time and cluster vij:
Y ijl ¼ β0 þ βj þ θXij þ ui þ vij þ eijl;
where vij ~N(0, σv
2) and where vij is assumed independ-
ent to ui. In this model, each cluster has a different ran-
dom effect at each time point and thus a different
deviation from the average secular trend – although the
degree of variation (as indicated by σv
2) is sampled from
the same distribution at all time points and for all clus-
ters [24]. It is convenient to think of vij representing the
variation within a cluster due to time varying character-
istics of the cluster.
One implication of including a random time by cluster
interaction is that it allows the intracluster correlation to
depend on whether observations are in the same time
period or in different time periods. In particular, it al-
lows for two different correlation coefficients:
ρW ¼
σ2u þ σ2v
σ2u þ σ2v þ σ2e
and
ρI ¼
σ2u
σ2u þ σ2v þ σ2e
;
where ρW represents the within-cluster, within-period
correlation and ρI the interperiod (same cluster) correl-
ation, with the restriction that ρI ≤ ρW. It is intuitive that
there may be a stronger correlation between observa-
tions within the same cluster and period than between
observations within the same cluster but in different pe-
riods. We note that this model specification is analogous
to specifications proposed for two period cluster rando-
mised cross-over trials [17]. An alternate but equivalent
specification is with the use of ρI/ρW rather than ρI,
which has been termed the cluster autocorrelation [25].
On the downside this model assumes that the correl-
ation between two observations taken at different times
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is the same irrespective of how far apart in time those
observations are made.
Extensions to allow for treatment-effect heterogeneity
across clusters
In multicentre individually randomised trials, in which
centres can have both treatment and control observa-
tions, treatment-effect heterogeneity can be investi-
gated by including a treatment by centre interaction
[26]. In stepped wedge trials, because each cluster is
both exposed and unexposed, it is also possible to
model treatment by cluster interactions. Others have
already considered the issue of allowing for treatment
by cluster heterogeneity in power calculations for
stepped wedge trials [18, 27], although here we
propose slightly different model parameterisations
which make less restrictive assumptions. Extensions
to allow for treatment-effect heterogeneity are consid-
ered in model extensions C to E below, first using
fixed effects and then using random effects.
Model extension C: varying treatment effect across strata of
clusters – using fixed effects
In addition to examining heterogeneity in secular trends
across strata, it might also be reasonable to examine
treatment-effect heterogeneity across strata. So, in our
case study set across two different hospitals, there may
be pragmatic interest in how the treatment effect varies
across these hospitals. This can be incorporated by in-
cluding a fixed-effect interaction between treatment and
strata, to model the different treatment effects in each
stratum/strata:
Y i sð Þjl ¼ β0 þ βj þ θXi sð Þj þ θsXi sð ÞjZi sð Þ þ ui þ ei sð Þjl;
using the same notation as earlier, where Zi(s) repre-
sents a stratum covariate and now θs represents a
fixed-effect interaction between treatment status and
stratum (again constrained such that θs is 0 for the
last strata).
The model includes a single underlying secular trend
for all strata, but a different shift in treatment effect (con-
stant over time) for each stratum. Interest in treatment-
effect variation by strata may have very practical implica-
tions, as it allows addressing the question of whether or
not a treatment was effective in a subgroup of clusters.
Model extension D: treatment-effect heterogeneity across
clusters – using random effects
Where interest lies in examining treatment-effect het-
erogeneity across clusters themselves, rather than fixed
subgroups of clusters, this can be achieved by including
a random interaction between treatment and cluster. We
parameterise this model as follows:
Y ijl ¼ β0 þ βj þ θXij þ uTiXij
þ uCi 1−Xij
  þ eijl:
The two random-effect terms uTi and uCi represent the
random interaction between treatment status and clus-
ter. These two random effects have a different variance
parameter for those exposed (uTi ~N(0, σT
2 )) and those
unexposed (uCi ~N(0, σC
2 )); and importantly, a covari-
ance between these two random effects (σTC). Note that
this model allows the variability between clusters to dif-
fer between the intervention and control periods.
This parameterisation implies different pairwise corre-
lations within clusters, depending on whether observa-
tions are both unexposed, both exposed, or one exposed
and one unexposed. In particular, it implies:
ρCT ¼
σCTﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ2C þ σ2e
 
σ2T þ σ2e
 q ; ρCC
¼ σ
2
C
σ2C þ σ2e
; and ρTT ¼
σ2T
σ2T þ σ2e
;
where ρCT represents the correlation between two obser-
vations in the same cluster but with different exposures;
and ρTT and ρCC the correlations between two observa-
tions in the same cluster and same treatment exposures.
There is no restriction as to which of these correlations
are larger due to the inclusion of the covariance term.
Extensions to allow for treatment-effect heterogeneity
across time
In addition to treatment heterogeneity across clusters,
treatment effects might vary with time. Because the SW-
CRT is run over multiple time periods it is possible to
investigate treatment by time interactions. Others have
considered delayed treatment effects (i.e. an interaction
between treatment and time since the cluster was ex-
posed) [27]. We consider extending the basic model for
treatment heterogeneity that varies over step. That is, we
consider a fixed-effect interaction between time period
and treatment.
Model extension E: treatment-effect heterogeneity across
time – using fixed effects
Interest might lie in determining whether treatment ef-
fects vary across time. This can be achieved by extending
the basic Hussey and Hughes model to include a fixed
interaction between treatment status and time period
(step). We parameterise this model as follows:
Y ijl ¼ β0 þ βj þ θXij þ θjXij þ ui þ eijl:
This model again assumes that each cluster follows
the same piecewise secular trend, but this model allows
the treatment effect to differ at each randomisation step
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in the study. Again for identifiability, the treatment effect
in the last time period is constrained to be 0 (θT = 0).
Note that this model extension modifies the fixed-
effects components only and makes no modifications to
the underlying correlation structure. We note that this
fixed-effect interaction will be estimable only at time pe-
riods in which there are both exposed and unexposed
observations. So, in our case study, this will be across
weeks 13 to 26.
Results
Each of the models described above was fitted to the
case study. Recall that the primary aim in the case
study was to evaluate whether there is a difference in
the probability of women’s membranes being swept
during labour both before and after the intervention.
We fitted several models: an inappropriate model that
does not account for time; the Hussey and Hughes
basic model; and each of the model extensions de-
scribed in the previous section. We report ORs, and
so fit the logistic regression model.
These models can be fitted in any statistical package,
such as SAS, R, or Stata. We used Stata 14 to fit models
using the melogit function using maximum likelihood
methods. This function uses mean-variance adaptive
Gauss-Hermite quadrature (Stata’s default estimation
method). We used the default number of integration
points (7) and default starting values. For one model (ex-
tension D) we observed convergence difficulty using the
melogit function and used the xtmelogit function instead
– which is recommended by Stata as an alternative in
cases of variance components being near the boundary
of the parameter space.
We estimate the ICCs on the logistic scale [28] using
the estat function where possible (although in more
complicated models we estimate the ICC simply by tak-
ing the ratio of variances and for these cases no confi-
dence interval for the ICC is provided). We provide
sample Stata code as Additional file 1. The results are
summarised in Table 1. Of note there are 10 randomisa-
tion steps, but 13 time periods in which there are both
control and intervention observations, for which a treat-
ment by time interaction is potentially estimable.
Basic model and implications of naïve (unadjusted for
time) estimates
Based on the observed data, there was a very small in-
crease in the proportion of women swept in the period
after exposure to the intervention (44.3% versus 46.4%).
The naïve analysis, which accounts for treatment and a
random effect for cluster (but not time), found a positive
but nonstatistically significant effect of the intervention
(OR 1.11; 95% CI 0.95 to 1.30). When modelling time as
a categorical variable in those not exposed to the
intervention there was some evidence of a small in-
creasing trend over time in the proportion of women
being swept (Fig. 3). Most notably, after adjusting for
this secular trend, the estimated odds ratio shifted
from favouring the intervention to favouring the con-
trol. In particular, the adjusted analysis found a
Table 1 Estimates of treatment effect from the Hussey and Hughes model; and model extensions
Model Unexposed to intervention Exposed to intervention Odds ratio
(95% CI)
ICC (95% CI)
N = 1420 N = 1367
Number swept 629 (44.3%) 634 (46.4%)
Unadjusted for time models
Naïve model 1.11 (0.95, 1.30) 0.069 (0.028, 0.161)
Time-adjusted models
Basic Hussey and Hughes model 0.78 (0.55, 1.12) 0.073 (0.030, 0.168)
Model extensions
A: Time by strata interaction (FE) 0.80 (0.55, 1.17) 0.075 (0.030, 0.176)
B: Time by cluster interaction (RE)a 0.79 (0.55, 1.14) 0.073 (0.030, 0.168)
0.078 (0.032, 0.177)
C: Treatment by strata interaction (FE)b 0.85 (0.58, 1.23) 0.066 (0.026, 0.156)
0.80 (0.57, 1.13)
D: Treatment by cluster interaction (RE)c 0.76 (0.52, 1.12) 0.016; 0.045; 0.027
E: Treatment by time interaction (FE)d 0.86 (0.21, 3.49) 0.075 (0.030, 0.171)
CI confidence interval, ICC intracluster correlation, FE fixed-effect interaction, RE random-effect interaction. aICCs presented are within same cluster same period;
and same cluster different period; bTreatment effects for two strata (hospital A and hospital B); cICCs presented are within same cluster both treated; and same
cluster both untreated; and same cluster different treatment; dTreatment effect given is at mid study week 20 – others are depicted in Fig. 4. Note the ICC is re-
ported on the logistic scale and so is not to be used for planning purposes. All models adjust for clustering
Note the summaries of number and proportion swept in first two columns are unadjusted for time and so should not be interpreted as representative of the
treatment effect. Estimates from model D are using xtmelogit as melogit failed to converge
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negative, but nonstatistically significant effect of the
intervention (OR 0.78; 95% CI 0.55 to 1.12). The esti-
mated ICC was 0.073 (95% CI 0.030, 0.168).
Models allowing for different secular trends
The case study was set across two different hospitals
and so it is very possible that background trends differed
between these two hospitals. We therefore allowed secu-
lar trends to vary across these two hospitals (model ex-
tension A). We observed no clear difference in
underlying secular trends between the two hospitals
(Figure not shown): inclusion of this term resulted in a
nonsignificant interaction and the overall conclusions
about the treatment effect did not change substantially
(Table 1). We also fitted model extension B, allowing for
random variation in the secular trend across the 10 clus-
ters, as it seemed intuitive that as the study was con-
ducted over 40 weeks that some time-dependent
random variation was to be expected. Whilst we found
that the correlation between observations in different
time periods (0.073; 95% CI 0.030, 0.168) was slightly
lower than between observations within the same time
period (0.078; 95% CI 0.032, 0.177), the estimated treat-
ment effect did not change substantially (Table 1). When
fitting these model extensions, which allowed for differ-
ing secular trends, we observed an increase in the width
of the confidence intervals, reflecting a decrease in pre-
cision associated with fitting a more flexible model.
Models allowing for treatment-effect heterogeneity
When we allowed for a fixed-effect interaction to inves-
tigate treatment-effect heterogeneity across the two hos-
pitals, we found that the interaction was not significant
and the treatment effects similar between the two strata
(Table 1, model extension C). In the model in which a
random treatment by cluster interaction was included
(model extension D), we observed some indication that
the correlation was lower between observations which
were treated (point estimate 0.016) than between obser-
vations which were not treated (point estimate 0.045).
However, the treatment estimate changed little on allow-
ing for this extra heterogeneity (Table 1). Allowing for
treatment by time (step) interactions (model extension
E) was uninformative as confidence intervals were very
wide (Fig. 4). Again, all confidence intervals widened
reflecting the decrease in precision associated with fit-
ting these more complex models.
Discussion
The SW-CRT is a novel study design which is increasing
in popularity and can be potentially valuable in the
evaluation of service delivery and policy interventions
[1, 2]. A recent systematic review found that a substan-
tial proportion of stepped wedge studies published to
date had failed to adjust for secular trends in the esti-
mated treatment effect [9, 10]; and recent papers in
high-impact journals have also failed to adjust for this
confounder [14, 29]. We have demonstrated in this
paper the consequences of not adjusting for time.
Underlying secular trends in those clusters unexposed
to the intervention in our example illustrates the real
possibility of changes over time in the outcomes, irre-
spective of any intervention. Furthermore, the common
modelling framework proposed for the analysis of the
SW-CRT by Hussey and Hughes – which does allow
for secular trends – makes a number of assumptions.
These include the assumption of a common underlying
secular trend and a simple shift under treatment expos-
ure across all clusters and all time periods. In this
paper, we demonstrated how to explore sensitivities to
deviations from these basic model assumptions. Whilst
our case study did not prove to be sensitive to these
model assumptions, it is important to note that this is
unlikely to be the case in all studies.
Fig. 3 Model-based estimate of underlying temporal trend in primary outcome over duration of trial in unexposed clusters (black line) and
model-based estimated of outcome in intervention periods (red line) – basic model for the case study. Point estimates and 95% CI for each step
with smoothed (LOWESS) line overlaid (black control; red intervention)
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The impact of secular trends
In our example, we observed how the primary out-
come increased over time in clusters unexposed to
the intervention. The implication of this was that an
intervention which prima facie appeared effective, al-
beit with a small impact, actually transpired to be
suggestive of an intervention which had an effect in
the opposite direction. There are several possible ex-
planations for this finding [5]. Firstly, the fully ad-
justed confidence intervals did not rule out that the
intervention may indeed be beneficial (i.e. the result
was not statistically significant). Alternatively, contam-
ination might be an explanation; that is, the unex-
posed clusters becoming exposed to the intervention
before their randomised cross-over point. But, it
might be the case that external to this intervention
and study, other nationwide initiatives began, some-
times described as a rising tide [30].
Modelling secular trends
Because of the inherent imbalance in treatment over
time it is imperative that the primary analysis of a SW-
CRT adjusts for time irrespective of whether it is statisti-
cally significant. Time is a strong candidate for having a
confounding effect in almost every SW-CRT and this lo-
gical reasoning should dictate its criteria for inclusion
rather than a reliance on statistical significance testing,
or lack of, which is not useful for determination of con-
founding [31]. In our example we observed the effect of
calendar time to be reasonably linear. Modelling a linear
trend will require fewer degrees of freedom than model-
ling as a categorical variable and so should provide in-
creased precision for the treatment effect. With a large
number of steps, or where time is recorded continu-
ously, it should also be possible to model the secular
trend using quadratic or cubic terms, or even fractional
polynomials [32] or restricted cubic splines. With more
than about four or five measurement occasions (or when
time is measured continuously), fitting a parametric
trend for time might result in more powerful statistical
tests assuming that the modelled parametric trend actu-
ally provides a reasonable approximation to the true
underlying shape [33].
Extensions from the basic Hussey and Hughes model
The Hussey and Hughes model is becoming standard for
use in the analysis of the SW-CRT. In our review we
have identified that of the 32 published trials – 17 of
these adjusted for secular trends and of these 7 used the
Hussey and Hughes model [9]. We did not identify any
studies that considered deviations from the basic model
– either by modelling more flexible secular trends or ex-
ploring treatment heterogeneity. Yet, the Hussey and
Hughes model makes some important implicit assump-
tions, namely, that the underlying secular trend is identi-
cal across all clusters, and that the treatment produces a
constant shift in this trend which is identical across all
clusters and time points. It is important that these as-
sumptions are recognised so that their appropriateness
can be considered. We have outlined these assumptions
and considered how they may be extended. We consid-
ered extensions in which the secular trend was allowed
to vary across clusters and the treatment effect was
allowed to vary across clusters and time [34].
Correctly modelling the secular trend is important,
otherwise the secular change might be mistakenly attrib-
uted to the intervention. Modelling treatment-effect het-
erogeneity might be considered less important if interest
is in the average treatment effect but will affect the pre-
cision of the treatment effect. Furthermore, implicit in a
-2
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Fig. 4 Model-based estimate of treatment effect (ln odds ratio, OR) over duration of trial. Point estimates and 95% CI for each time period in
which observations were both exposed and unexposed to intervention
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model that assumes a single random intercept for the
cluster is that the correlation between two observations
in the same cluster is independent of their treatment
status, an assumption that seems untenable. We ob-
served a slight decrease in precision when we fitted
these more complex models and this is to be expected
more generally and is a reflection of model complexity.
This will of course have implications on power – to the
extent that appropriate consideration of these model ex-
tensions at the power stage will result in an increase in
sample size needed [22, 23].
We considered both extensions using random- and
fixed-effect parameters. For the fixed-effects models we
group clusters into strata. In our case study, the stratum
is hospital as the study was set across two hospitals.
Other choices for strata will be dependent on context.
Fixed effects might be appropriate where there is a clear
clinical interest in the effect of these strata. So, in our
case study a clinical interest in whether the treatment ef-
fect varies by these particular hospitals. There are clearly
downsides though to the use of fixed effects as it will
quickly reduce the degrees of freedom when the number
of strata becomes large. Furthermore, when modelling
the secular trend, the secular trend might be expected to
vary across all clusters and not just across strata.
In our case study we did not find model choice to have
an impact on the treatment effect or its precision (other
than the model in which time was not included). This
cannot and should not be taken as a generalisable result
– we expect model misspecification to have a large im-
pact in some situations. Indeed, model misspecification
in generalised linear mixed models is known to be im-
portant, as others have demonstrated in clustered data
[35]. Misspecification can arise because of either misspe-
cification of the model for the mean or misspecification
of the correlation structure. Misspecification of the
mean might arise because of cluster-specific variation in
secular trends perhaps, but these sorts of misspecifica-
tions depend on the study and so are difficult to investi-
gate generically. Misspecification of the correlation
structure, however, can be investigated generically – and
so, for example, future simulation studies should investi-
gate the impact on bias and precision of treatment ef-
fects estimated when there is decay in the correlation
overtime but where this is ignored at the analysis stage.
Limitations
Although we have described extensions to the Hussey
and Hughes approach, we did not examine the conse-
quences of model misspecification on bias, coverage and
power using simulations. There were also other exten-
sions to the basic model which we did not consider. For
example, an extension that we did not consider was to
impose a structure on the cluster-level covariance over
time, such as linear or autoregressive decay in correla-
tions over time. However, we did allow for an interaction
between the time trend and some strata variable, but this
will only be feasible where there is a natural choice for
strata as it is not possible to model an interaction be-
tween cluster and time as a fixed effect [36].
We limited our consideration to the generalised linear
mixed model, but generalised estimating equations
(GEEs) also allow for nonindependence in cluster trials
[37]. Within the context of the SW-CRT, finite sample
GEE correction methods have been proposed, but these
are not widely available in Stata yet (though they are
available in R) [38]. Including cluster as a fixed effect is
a possibility; as too is an analysis using cluster-level
means [39]; or something described by others as a verti-
cal analysis [40]. Vertical analyses involve separate ana-
lyses at each time period and pooling time-specific
treatment effects – using some sort of weighting
methods. Vertical analyses are likely to make fewer as-
sumptions, but at a cost of being less powerful [8].
We have also identified some more technical issues along
the way. We observed model convergence issues with one
of the model extensions (model D), which we were able to
overcome using a different method of optimisation. We
were also unable to obtain treatment by time interactions
for all of our randomisation step points – due to scarcity of
data. These complex models were fitted to data with only
10 clusters, and without any small sample correction fac-
tors. Others have shown that this may have implications on
bias and coverage, especially when using GEEs [38]. Finally,
we reported correlations on the logistic scale. It is well
known that for planning parallel cluster trials the ICC
needed is on the proportions scale. However, whether the
same principals apply to other correlations (such as inter-
period correlations) is unknown. We also did not report
confidence intervals for all correlation parameters, due to
current statistical package limitations.
We have stopped short of providing recommendations
for which of these models should be used for the primary
analysis, have not considered issues of multiple testing nor
consequences of lack of a priori model prespecification.
Whilst these issues are very important, our aim has been
to raise awareness of the assumptions implicit in the Hus-
sey and Hughes model and provide some but not all pos-
sible model extensions. Future work lies in determining
consequences of model misspecification, which can then
help with recommendations for primary analysis. We
would recommend that the model used should be selected
prior to analysing the data and should not be data driven.
Until the consequences of model misspecfication are
known, we would recommend that the primary analysis
consist of the Hussey and Hughes model, and sensitivity
of results to departures from the model (as outlined here)
should be considered and reported.
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Conclusions
The SW-CRT is particularly appealing as it offers a means
of conducting a randomised trial within a naturalistic set-
ting. In order to successfully determine the effectiveness
of an intervention evaluated using a SW-CRT, it is neces-
sary to use appropriate analysis techniques because simple
summary statistics (grouped by those exposed and not ex-
posed to the intervention) will not be a fair summary of
the effect of the intervention. In essence, this means that
there is a necessity for allowing for underlying secular
trends and it is this time-adjusted effect of the interven-
tion which is the unbiased estimate of how the interven-
tion works. This adjusted effect, as shown in our
examples, can be quite different to the unadjusted effect.
Furthermore, whilst the model proposed by Hussey
and Hughes is becoming increasingly used at the ana-
lysis stage, which does indeed adjust for time, it is im-
portant to appreciate the assumptions implicit within
this model – both the assumptions that are being made
about secular trends and treatment effects; and the im-
plied assumptions on the correlation structure. Further
work, likely using simulation studies, is needed to deter-
mine if model misspecification has important conse-
quences in terms of bias or standard error of the
intervention effect estimate.
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